Finoriq research workspace
QuidelOrtho Corp (QDEL) SEC Filings & Filing Highlights
QuidelOrtho Corporation provides diagnostic testing solutions. Review QDEL SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
- Company
- QuidelOrtho Corp (QDEL)
- Ticker
- QDEL
- Market Cap
- $1.1B
- Latest Price
- $16.8
- Industry
- Diagnostics
QuidelOrtho Corp (QDEL) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for QuidelOrtho Corp (QDEL).
| Event | Form | Date |
|---|---|---|
| QuidelOrtho Appoints Micah Young as Chief Financial OfficerQuidelOrtho Appoints Micah Young as Chief Financial Officer | 8-K7.01 | 2026-06-23 |
| Announcement of New Chief Financial Officer The Board of Directors of QuidelOrtho Corporation (...Announcement of New Chief Financial Officer The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to... | 8-K5.02 | 2026-06-23 |
| The Company’s stockholders elected the ten director nominees to the Company’s Board of Director...On June 16, 2026, QuidelOrtho Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The followin... | 8-K5.07 | 2026-06-16 |
| QuidelOrtho Reports First Quarter 2026 Financial ResultsQuidelOrtho Reports First Quarter 2026 Financial Results | 8-K2.02 | 2026-05-05 |
| QuidelOrtho Corp: Earnings or resultsOn April 15, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing its preliminary unaudited revenue for its firs... | 8-K2.02 | 2026-04-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.